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During the 20th and early 21st centuries, the discipline of 
environmental health has contributed to tremendous improve-
ments in air, water, and food quality; occupational health; waste 
management practices; and disease vector control. As a result 
of these and other improvements, prevention and treatment 
of infectious disease (eg, those caused by biological agents) 
and non-infectious disease (eg, those caused by chemical or 
physical agents) has improved significantly around the world. 
However, substantial challenges remain, particularly in devel-
oping countries with limited health resources relative to more 
developed countries. Examples include recent (summer, fall, 
2014) concerns for the Ebola virus and non-polio enterovi-
rus D68 (EV-D68). There are also previous and ongoing con-
cerns for diseases such as sudden acute respiratory syndrome 
(SARS); H1N1 influenza; other swine and avian influenza 
(swine, bird flu); and a variety of other viral, bacterial, and 
protozoal diseases.
Are the risks of transmission of infectious diseases such 
as Ebola actually increasing, or is the public just more aware 
of the problem because of the efficiency of the global media in 
identifying infectious disease outbreaks?
As an example, Ebola hemorrhagic fever has been in the 
news during summer and fall 2014 because of the outbreaks 
and related infections of health-care providers in Africa. Ebola 
transmission is accomplished via direct or indirect exposure to 
blood or other bodily fluids, and is therefore relatively easily 
controlled by the use of personal protective equipment such 
as gloves, masks, safety glasses, and Tyvek™ suits (Centers 
for Disease Control and Prevention [CDC]).1 Therefore, the 
risks of an Ebola pandemic would appear to be low. However, 
there are concerns that Ebola could become an epidemic and/or 
endemic disease in Africa. A September, 2014 CDC Morbid-
ity and Mortality Weekly Report Supplement predicted that 
there could be as many as 1.4 million cases in Liberia and Sierra 
Leone by January, 2015 (http://www.cdc.gov/mmwr/preview/
mmwrhtml/su6303a1.htm?s_cid = su6303a1_w).2 It should be 
noted, however, that the authors outlined significant limitations 
to this prediction. There has also been public concern expressed 
about bringing infected health-care workers to the US because 
of the perceived potential for an outbreak of Ebola. Identifi-
cation and treatment of specific Ebola symptoms and use of 
an experimental monoclonal antibody treatment (ZMapp™, 
developed by Mapp Biopharmaceutical Inc.) to manage the dis-
ease process appear promising. There is also an Ebola vaccine 
that began US National Institutes of Health (NIH) human 
testing in October, 2014.3
Other diseases in the news during the past decade may 
be more easily transmitted than Ebola, particularly those that 
are airborne. SARS, transmitted by an airborne coronavirus, 
was a major concern in 2003, but fortunately, no cases have 
been reported worldwide since 2004.4 The US Public Health 
Emergency of 2009 for H1N1 influenza strain expired in June, 
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2010, and the World Health Organization (WHO) announced 
in 2010 that H1N1 had moved into the post-pandemic period.5 
Although influenza may initially cycle in animals such as pigs 
and birds (zoonoses), “variant” forms of viruses may contribute 
to sporadic, unpredictable human infection outbreaks. These 
infections are usually the result of direct or indirect contact 
with animals such as swine and poultry, but may also be trans-
mitted among humans under the right conditions. EV-D68 
has also been of recent concern in summer and fall, 2014, for 
individuals with pre-existing respiratory conditions such as 
asthma or respiratory diseases.6,7 Influenza vaccines target 
those viruses predicted to be most common for that season. 
For example, the US 2014–15 flu vaccine will include influ-
enza A H1N1, H3N2, and one or two influenza B viruses, 
depending on the version of the vaccine used.8
An emerging disease is identified by the WHO as “one 
that has appeared in a population for the first time, or that 
may have existed previously, but is rapidly increasing in 
incidence or geographic range.9” The term re-emerging indi-
cates that the disease is emerging once again in the same 
or perhaps a different geographic area. The emergence or 
re-emergence of an infectious disease may be complicated 
by reservoirs of the disease (such as domesticated or wild 
animals) resulting in sporadic outbreaks among humans. 
A variety of environmental factors may contribute to re/
emergence of a particular disease, including temperature, 
moisture, human food or animal feed sources, etc. Disease 
re/emergence may be caused by the coincidence of several 
of these environmental and/or social factors to allow opti-
mal conditions for transmission of the disease. For example, 
Ebola virus is transmitted to humans from wild animals 
and then spreads via human-to-human transmission. It is 
believed that fruit bats are natural Ebola virus hosts and 
that the virus is introduced to humans via infected animals 
such as chimpanzees, gorillas, fruit bats, etc. found dead or 
ill in the rainforest.10
It seems likely that a wide variety of infectious diseases 
have affected human populations for thousands of years 
emerging when the environmental, host, and agent condi-
tions were favorable. Expanding human populations have 
increased the potential for transmission of infectious disease 
as a result of close human proximity and increased likelihood 
for humans to be in “the wrong place at the right time” for 
disease to occur (eg, natural disasters or political conflicts). 
Global travel increases the potential for a carrier of disease to 
transmit infection thousands of miles away in just a few hours, 
as evidenced by WHO precautions concerning international 
travel and health.11
So what can environmental health professionals do to help 
to limit transmission of infectious disease and accurately edu-
cate the public on the associated risks? Firstly, quality research 
is the foundation of a better understanding of how, when, and 
where disease agents are transmitted through the environment 
so that appropriate controls can be implemented to reduce the 
potential for disease transmission. Secondly, enforcement of 
proper environmental health regulations (eg, air, water, food, 
occupational health, waste management, vector control, etc.) 
by environmental health practitioners at the local, regional, 
national, and international level serves a vital role in limiting 
disease transmission. Finally, sharing and reinforcement of 
accurate information with the public concerning the potential 
for transmission of infectious disease and how it may be pre-
vented or controlled is an important role that environmental 
health professionals can play. For example, it has been specu-
lated that infectious disease transmission could be reduced by 
up to 80% by something as simple as appropriate, regular hand 
washing techniques.
We live in a global society where media shares informa-
tion almost instantaneously worldwide, so it is not surpris-
ing that knowledge of a disease outbreak thousands of miles 
away may create local concern. This concern may even be 
legitimate given the ability of humans to travel around the 
world within just a few hours. Movies and television showing 
the potential consequences of a pandemic (global) infection 
have also raised public awareness. However, human diversity 
and adaptability has thus far limited the spread of infectious 
disease. It is also important to note that of the top 10 leading 
causes of death worldwide as identified by the WHO, only 
three – lower respiratory infections, HIV/AIDS, and diar-
rheal disease (#4, #6, and #7, respectively) – have a clear 
infectious disease component.12 The rest of the causes are 
chronic diseases or accidents, which may be limited by per-
sonal habits such as an active lifestyle, lower fat diet, smoking 
cessation, and safer driving. While some media “sensational-
ism” of international infectious disease outbreaks is unavoid-
able, environmental health professionals can help to provide 
a more balanced view of the risks and share ways in which 
individuals can empower themselves to prevent or control 
both infectious and non-infectious diseases.
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